Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > Ecommerce > DXInOne - Issue #2 - We Have Enough DXInOne Marketers Already, Right?

Tags

  • money
  • being
  • combination products
  • developing combination

  • Links

  • In Search Of The Perfect Property Deal
  • Mdina The Silent City In Malta
  • Blend Your Strengths with Small Business Needs
  • Main Subject - DXInOne - Issue #2 - We Have Enough DXInOne Marketers Already, Right?

    Enough or Too Many?

    In 2005, we saw marketers appear like popcorn. Everywhere you looked, someone had a product over DXInOne. Everyone seemed to suddenly know the system, and they are more than ready to explain it to you: for a price, or for free, through audio/video-based training, through Adobe documents, through su
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    pport forums… You name it. Training everywhere.

    Doesn’t make much sense

    If there are so many training systems out there, then why aren’t enough reserves appearing to keep things smooth? Surely there should be a constant enough feed of fresh funds. There must be something else happening, right?

    You are right. There is more to
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    it than just the basic act of shepherding folks through the system. If it WAS that simple, then there wouldn’t be any problems with system volatility. Everything would be flowing along just fine.

    All right. Sit back and mull that one over… and it shouldn’t take you long to peg on it:

    Maybe it’s about just WHAT exactly the marketing sites are training
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    over.

    It’s what the marketing sites ARE training, on the whole. They are teaching their adherents, mainly, that this is a ‘cash production’ system. Namely, that everyone is supposed to be able to just add a few bucks, and forever make relatively consistent withdrawals.

    They aren’t just saying ‘sometimes it works that way, (if) or (when) etc.’ And ‘so
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    metimes it works another way, (if) or (when) etc.’

    They are just plain telling you that you can add a few dollars and keep pulling out more and more as you go. At all times, mainly. No matter what is happening with system reserves.

    Think of the biggest training systems during 2005, and think about what their training has been like. We dont mean their
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    marketing pages – sure, everyone tends to market for best image. As far as that goes, marketing is marketing.

    But marketing HAS TO BE counter-balanced by quality training. You have to be ready to be flexible in this system; to understand that the system is dynamic, and doesn’t just operate one way only.

    In short, when is it possible to withdraw more
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    than you put in? When the system is being marketed hard enough to drive more total e-currency/currency through the system than DXG in circulation. During THOSE times, we’re seeing ‘excess reserves’, which over 2005 were drained. Again, this issue existed also by the end of 2003, when we had to correct for that imbalance as well.

    How it work
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ed in 2005

    During 2005, this is inevitably how it worked:

    Many new members got in. And many older (senior) members already had cash in the system. Since everyone could buy digots using ‘old DXG’ directly to create ‘new DXG’, they surely did!

    And what did they do with the cash they got from OutXchanges…?

    You guessed it; they basically p
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    cketed that cash.

    They withdrew real money (reserves) consistently, while simultaneously creating more DXG by using their ‘old’ DXG.

    In effect, many who had little funds to work with put funds through the system, and the system allowed those who were already vested to higher levels to extract that money.

    I still remember Sharon Toberer excitedly tal
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    king about purchasing her husband a $10,000 electric car for his birthday, from DXG profits, because she thought ‘it was cute.’

    Where do you think she got the $10,000 …? She had put some money (about $4000) in the system already. She was vested. When someone InXchanged $10,000 and it arrived in her account (this is just an example of the sort of usual
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    thing that happened), she chose to cash that money out, and go on vacation, or make a purchase for the fun of it, or pay bills, etc. In this case, she bought an electric car (if I am remembering it correctly).

    Additional DXG

    Since she and so many of us were able to create a lot of additional DXG without having to add additiona
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    l funds, it really was simply a matter of who had the most DXG. Those with the ‘most’ DXG got to cash out the highest proportion of funds added to the system over time.

    We have had folks who retired for a full year already. They were retiring back in 2004 from the activity we were kicking up that year. Money came out of this system as fast as it went
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    in, basically. For every 15 folks who added $1000 each, there was someone who could list DXG for OutXchanges for $15,000 worth of monthly profits ($15,000 new DXG created by using old DXG to pay fees). The DXInOne System allowed for this, and creating an imbalance could be expected, if training systems did not do their job to help folks understand how
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    o balance. That much was always on our own shoulders, as trainers.

    During 2005, no one really HAD to InXchange funds consistently. There was really no requirement for ensuring cashflow throughout the system. Here is the problem, though…

    Back in early 2005 (even late 2004), a number of larger marketers discovered, to their delight, that they could put
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    some cash into the system, and start withdrawing larger amounts… over and over. They went crazy feeling that they had basically discovered ‘the holy grail,’ or the ‘internet’s hottest unknown business’, ‘why buy training when you can get it all here for free?’ etc. You’ve seen all the slogans from numerous sites.

    The problem

    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    hough there were enough marketers, they were sharing lousy training. All they ultimately taught their members was that they could put small amounts of money into the DXSystem, and keep withdrawing larger and still larger amounts.

    No sense of limitations. No bigger picture. No actual explanation of system cycles. No sense of how things worked. No descr
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    iption of what happens to money you InXchange.

    Just a basic marketing message, to sell courses. Hard and fast.

    The result was exactly what you would think… very many members brought into the system, with a wrong sense of objectives and of their job here at DXInOne.

    Most of them PUT perhaps $500 in. And over the next few months, got started withdrawi
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ng pretty consistently. They took their $500 back out as quickly as they could. And as much more as they could, for the most part.

    Maybe 85% of DXUsers generally were in the simple habit of withdrawing the entire time.

    Plenty of marketing. But most everyone being taught not nearly enough about system reserves balance techniques or needs – just how to
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ‘use old DXG to create new DXG while constantly withdrawing reserves added by other members in the meantime, keeping total reserves low.’

    The moral of the story

    What’s the moral of the story? Pretty simple, according to the ‘Big Reserves Drain of 2005!’

    Hard-core marketing can't replace quality training over DXInOne. One can'
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    t simplify DXInOne to basic push button standards and make the claim that you can simply sit around and produce cash out of thin air without borders or boundaries.

    Yet that’s exactly what went wrong. Too many marketers; not enough [real] trainers.

    In the next issue, we’ll talk about Marketing Vs. Fluidity: ‘which comes first – the chicken or the egg?


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/61189/mainsubjects-DXInOne--Issue-2--We-Have-Enough-DXInOne-Marketers-Already-Right.html">DXInOne - Issue #2 - We Have Enough DXInOne Marketers Already, Right?</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/61189/mainsubjects-DXInOne--Issue-2--We-Have-Enough-DXInOne-Marketers-Already-Right.html]DXInOne - Issue #2 - We Have Enough DXInOne Marketers Already, Right?[/url]

    Related Articles:

    Sales Management for Bike Manufacturers

    Business Development Tips For Speech Writing Business

    What Email Address Are You Using?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com